Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 EUR | +1.86% | +3.90% | -13.97% |
04-24 | CapMan to Sell Special Transport Group Havator | MT |
04-15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 362 | 362.1 | 475.3 | 427.5 | 363.7 | 347.7 | - | - |
Enterprise Value (EV) 1 | 378.4 | 387.3 | 493.1 | 464.9 | 416.5 | 397.9 | 385.5 | 363.2 |
P/E ratio | 26.2 x | 70.2 x | 14.2 x | 10.9 x | 286 x | 15.1 x | 10 x | 9.21 x |
Yield | 5.52% | 6.05% | 4.94% | 6.28% | 4.37% | 5.75% | 7.78% | 8.63% |
Capitalization / Revenue | 7.39 x | 8.42 x | 9 x | 6.33 x | 6.13 x | 4.95 x | 4.37 x | 4.12 x |
EV / Revenue | 7.73 x | 9.01 x | 9.34 x | 6.88 x | 7.02 x | 5.66 x | 4.85 x | 4.3 x |
EV / EBITDA | 15.2 x | 28 x | 10.7 x | 7.76 x | 50.6 x | 12.4 x | 8.25 x | 6.9 x |
EV / FCF | -410 x | -31.5 x | 45.3 x | 81.4 x | 34.5 x | 19.2 x | 11.3 x | 9.63 x |
FCF Yield | -0.24% | -3.17% | 2.21% | 1.23% | 2.89% | 5.21% | 8.88% | 10.4% |
Price to Book | 2.77 x | 3.18 x | 3.73 x | 3 x | 3.15 x | 2.35 x | 2.15 x | 1.96 x |
Nbr of stocks (in thousands) | 153,728 | 156,433 | 156,591 | 158,029 | 158,823 | 176,496 | - | - |
Reference price 2 | 2.355 | 2.315 | 3.035 | 2.705 | 2.290 | 1.970 | 1.970 | 1.970 |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 07/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 48.97 | 42.99 | 52.8 | 67.53 | 59.36 | 70.3 | 79.47 | 84.48 |
EBITDA 1 | 24.98 | 13.84 | 46.12 | 59.89 | 8.231 | 32 | 46.75 | 52.6 |
EBIT 1 | 25.04 | 12.34 | 44.6 | 55.71 | 6.74 | 31.03 | 44.23 | 48.2 |
Operating Margin | 51.14% | 28.7% | 84.47% | 82.49% | 11.35% | 44.14% | 55.66% | 57.05% |
Earnings before Tax (EBT) 1 | 17.61 | 9.219 | 40.6 | 47.63 | 4.01 | 27.63 | 41.23 | 45.28 |
Net income 1 | 15.88 | 5.142 | 34.32 | 39.62 | 1.346 | 22.33 | 33.73 | 36.83 |
Net margin | 32.42% | 11.96% | 65% | 58.66% | 2.27% | 31.77% | 42.45% | 43.6% |
EPS 2 | 0.0900 | 0.0330 | 0.2140 | 0.2480 | 0.008000 | 0.1306 | 0.1964 | 0.2139 |
Free Cash Flow 1 | -0.924 | -12.3 | 10.88 | 5.711 | 12.06 | 20.73 | 34.23 | 37.73 |
FCF margin | -1.89% | -28.6% | 20.62% | 8.46% | 20.31% | 29.49% | 43.07% | 44.66% |
FCF Conversion (EBITDA) | - | - | 23.6% | 9.54% | 146.49% | 64.79% | 73.23% | 71.74% |
FCF Conversion (Net income) | - | - | 31.72% | 14.42% | 895.84% | 92.84% | 101.48% | 102.44% |
Dividend per Share 2 | 0.1300 | 0.1400 | 0.1500 | 0.1700 | 0.1000 | 0.1133 | 0.1533 | 0.1700 |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 07/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 14.9 | 14.72 | 14.22 | 17.68 | 15.9 | 19.74 | 15.1 | 16.48 | 13.7 | 14.08 | 15.17 | 17.03 | 16.87 | 21.2 |
EBITDA 1 | 11.29 | 12.63 | 19.24 | 14.53 | 13.02 | 13.06 | 0.914 | 4.551 | 5.155 | -2.388 | 3.75 | 6.55 | 9.4 | 12.35 |
EBIT 1 | 10.92 | 12.24 | 18.86 | 14.11 | 12.62 | 10.06 | 0.529 | 4.173 | 4.805 | -2.767 | 2.867 | 6.867 | 9.333 | 11.87 |
Operating Margin | 73.29% | 83.19% | 132.7% | 79.81% | 79.39% | 50.98% | 3.5% | 25.32% | 35.07% | -19.66% | 18.9% | 40.31% | 55.34% | 55.97% |
Earnings before Tax (EBT) 1 | 10.16 | 11.09 | 16.3 | 13.02 | 12.17 | 6.144 | 0.032 | 3.836 | 4.691 | -4.548 | 2.067 | 6.033 | 8.523 | 11.03 |
Net income 1 | 9.014 | 9.028 | 13.32 | 11.64 | 10.2 | 4.452 | 0.305 | 3.336 | 3.385 | -5.681 | 1.533 | 4.667 | 6.7 | 8.967 |
Net margin | 60.5% | 61.35% | 93.74% | 65.79% | 64.15% | 22.55% | 2.02% | 20.24% | 24.7% | -40.36% | 10.11% | 27.4% | 39.72% | 42.3% |
EPS 2 | 0.0560 | 0.0560 | 0.0830 | 0.0730 | 0.0640 | 0.0280 | 0.002000 | 0.0210 | 0.0210 | -0.0360 | 0.006670 | 0.0233 | 0.0400 | 0.0533 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 27/10/21 | 03/02/22 | 28/04/22 | 04/08/22 | 27/10/22 | 02/02/23 | 28/04/23 | 03/08/23 | 26/10/23 | 07/02/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 16.4 | 25.2 | 17.8 | 37.4 | 52.8 | 50.2 | 37.8 | 15.5 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.656 x | 1.821 x | 0.386 x | 0.6244 x | 6.42 x | 1.568 x | 0.8093 x | 0.2947 x |
Free Cash Flow 1 | -0.92 | -12.3 | 10.9 | 5.71 | 12.1 | 20.7 | 34.2 | 37.7 |
ROE (net income / shareholders' equity) | 12.7% | 5.2% | 29.4% | 30.5% | 2.6% | 17.1% | 22.5% | 23.8% |
ROA (Net income/ Total Assets) | 7.52% | 2.36% | 15% | 16.5% | 1.21% | 8.58% | 10.6% | 10.2% |
Assets 1 | 211.1 | 217.7 | 229.5 | 239.7 | 111.5 | 260.2 | 318.8 | 359.8 |
Book Value Per Share 2 | 0.8500 | 0.7300 | 0.8100 | 0.9000 | 0.7300 | 0.8400 | 0.9200 | 1.010 |
Cash Flow per Share 2 | -0 | -0.0800 | 0.0700 | 0.0400 | 0.0800 | 0.1200 | 0.2200 | 0.2800 |
Capex 1 | 0.56 | 0.39 | 0.14 | 0.33 | 0.03 | 12.2 | 1.6 | 1.6 |
Capex / Sales | 1.15% | 0.9% | 0.27% | 0.49% | 0.04% | 17.4% | 2.01% | 1.89% |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 07/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.97% | 371M | |
+3.65% | 31.94B | |
0.00% | 17.45B | |
+6.42% | 5.54B | |
-0.42% | 3.08B | |
+15.23% | 2.98B | |
+22.64% | 2.9B | |
-18.98% | 2.24B | |
+4.02% | 1.23B | |
-2.00% | 1.07B |
- Stock Market
- Equities
- CAPMAN Stock
- Financials CapMan Oyj